Evidence map›Paper›PMID 21042838›Full record

ArticlePharmaceutical research2011

A new in situ brain perfusion flow correction method for lipophilic drugs based on the pH-dependent Crone-Renkin equation.

Alex Avdeef, Na Sun

Open access · greenAbstract readComparative Study
In one paragraph

Article in Pharmaceutical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Review
  4. Article
  5. Article
  6. Revisiting atenolol as a low passive permeability marker.Fluids and barriers of the CNS · 2017
    Article
  7. Review
  8. In vitro, in vivo and in silico models of drug distribution into the brain.Journal of pharmacokinetics and pharmacodynamics · 2013
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Alex AvdeefpION INC, 5 Constitution Way, Woburn, Massachusetts 01801, USA. aavdeef@pion-inc.com
Na Sun
Sumitomo Dainippon Pharma (United States) · US

Funding

Novel Approaches to Blood Brain Barrier FunctionR44MH075211 · NIMH · PION, INC · PI AVDEEF, ALEX · 2007 to 2009
$1.2M
NIMH NIH HHS R44 MH075211NIMH NIH HHS R44MH75211
6 · The paper itself

Abstract

purposeTo determine the flow-corrected luminal permeability, P(c), of lipophilic drugs measured by the in situ brain perfusion method under circumstances where the traditional Crone-Renkin equation (CRE) method, using diazepam as a flow marker, often fails.

methodsThe pH-dependent rate of brain penetration of five lipophilic drugs (amitriptyline, atomoxetine, imipramine, indomethacin, maprotiline, sertraline), as well as of atenolol and antipyrine, were measured in Sprague-Dawley rats. A new pH-dependent CRE was derived and applied to remove the hydrodynamic component of effective permeability, P(e), to produce P(c) values.

resultsIt was shown by the analysis of the in situ data in the pH 6.5-8.5 interval for the lipophilic bases that the average vascular flow F(pf) = 0.036 mL∙g(-1)∙s(-1), centered in a "flow-limit window" (FLW) bounded by P (e) (min)  = 170 and P (e) (max)  = 776 (10(-6) cm∙s(-1) units). It was shown that the traditional CRE is expected not to work for half of the molecules in the FLW and is expected to underestimate (up to 64-fold) the other half of the molecules.

conclusionThe new pH-CRE flow correction method applied to lipophilic ionizable drugs, based on the pH partition hypothesis, can overcome the limitations of the traditional CRE.

Indexed as

AnimalsBlood-Brain BarrierBlood Flow VelocityBrainHydrogen-Ion ConcentrationMaleMembrane LipidsPharmaceutical PreparationsRandom AllocationRatsRats, Sprague-DawleyMembrane LipidsPharmaceutical Preparations

Identifiers

PMID21042838
PMCPMC3076090
OpenAlexW1998091397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.